(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. Localization of active BMP and TGFß signal transduction in the
developing kidney. Nuclear immunohistochemical staining for phospho-Smad1
(pSmad1) and phospho-Smad2 (pSmad2) identifies cells actively responding to
BMP and TGFß signals, respectively. At E11.5 (A,B), activation is mainly
within the metanephric mesenchyme, with responding cells disseminated
throughout the mesenchyme. The ureteric bud contains a small number of
positive cells. At E12.5 (C,D), pathway activation is predominantly within the
peripheral and mature stroma. Few positive cells are seen in nephrogenic
mesenchyme and collecting ducts. At E13.5 (E,F), activation is seen in
peripheral and mature stroma. Nephrogenic mesenchyme and epithelial structures
such as comma-shaped bodies show little staining. Tips and trunks of
collecting ducts show activation. (G) RT-PCR for expression of components of
the TGFß superfamily pathway in (K) E11.5 kidneys and (E) control E17.5
embryos. CD, collecting duct; CB, comma-shaped body; Mes, metanephric
mesenchyme; MS, mature stroma; NM, nephrogenic mesenchyme; TR, collecting duct
trunk; UB, ureteric bud.